Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus.

dc.contributor.author

Sun, Kai

dc.contributor.author

Molokwu, Nneka J

dc.contributor.author

Hanlen-Rosado, Emily

dc.contributor.author

Corneli, Amy L

dc.contributor.author

Pollak, Kathryn I

dc.contributor.author

Rogers, Jennifer L

dc.contributor.author

Sadun, Rebecca E

dc.contributor.author

Criscione-Schreiber, Lisa G

dc.contributor.author

Doss, Jayanth

dc.contributor.author

Bosworth, Hayden B

dc.contributor.author

Clowse, Megan EB

dc.date.accessioned

2024-06-27T19:44:19Z

dc.date.available

2024-06-27T19:44:19Z

dc.date.issued

2024-06

dc.description.abstract

Objective

Medication nonadherence in systemic lupus erythematosus (SLE) leads to poor clinical outcomes. We developed a clinician-led adherence intervention that involves reviewing real-time pharmacy refill data and using effective communication to address nonadherence. Prior pilot testing showed promising effects on medication adherence. Here, we describe further evaluation of how clinicians implemented the intervention and identify areas for improvement.

Methods

We audio recorded encounters of clinicians with patients who were nonadherent (90-day proportion of days covered [PDC] < 80% for SLE medications). We coded recordings for intervention components performed, communication quality, and time spent discussing adherence. We also conducted semistructured interviews with patients and clinicians on their experiences and suggestions for improving the intervention. We assessed change in 90-day PDC post intervention.

Results

We included 25 encounters with patients (median age 39, 100% female, 72% Black) delivered by 6 clinicians. Clinicians performed most intervention components consistently and exhibited excellent communication, as coded by objective coders. Adherence discussions took an average of 3.8 minutes, and 44% of patients had ≥ 20% increase in PDC post intervention. In structured interviews, many patients felt heard and valued and described being more honest about nonadherence and more motivated to take SLE medications. Patients emphasized patient-clinician communication and financial and logistical assistance as areas for improvement. Some clinicians wanted additional resources and training to improve adherence conversations.

Conclusion

We provide further evidence to support the feasibility, acceptability, and fidelity of the adherence intervention. Future work will optimize clinician training and evaluate the intervention's effectiveness in a large, randomized trial.
dc.identifier

jrheum.2024-0071

dc.identifier.issn

0315-162X

dc.identifier.issn

1499-2752

dc.identifier.uri

https://hdl.handle.net/10161/31213

dc.language

eng

dc.publisher

The Journal of Rheumatology

dc.relation.ispartof

The Journal of rheumatology

dc.relation.isversionof

10.3899/jrheum.2024-0071

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.title

Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus.

dc.type

Journal article

duke.contributor.orcid

Sun, Kai|0000-0002-8406-2932

duke.contributor.orcid

Corneli, Amy L|0000-0002-4629-4329

duke.contributor.orcid

Pollak, Kathryn I|0000-0002-5559-2416

duke.contributor.orcid

Sadun, Rebecca E|0000-0001-7768-3565

duke.contributor.orcid

Bosworth, Hayden B|0000-0001-6188-9825

duke.contributor.orcid

Clowse, Megan EB|0000-0002-8579-3470

pubs.begin-page

jrheum.2024

pubs.end-page

jrheum.0071

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Staff

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Medicine

pubs.organisational-group

Obstetrics and Gynecology

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Medicine, Rheumatology and Immunology

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

University Initiatives & Academic Support Units

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Duke Global Health Institute

pubs.organisational-group

Center for the Study of Aging and Human Development

pubs.organisational-group

Initiatives

pubs.organisational-group

Duke Science & Society

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Duke Innovation & Entrepreneurship

pubs.organisational-group

Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences

pubs.organisational-group

Duke-Margolis Institute for Health Policy

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
jrheum.2024-0071.full.pdf
Size:
402.92 KB
Format:
Adobe Portable Document Format